Core Viewpoint - He Yuan Bio is set to become a new member of the Sci-Tech Innovation Board as it officially starts its issuance process, marking a significant step in the "1+6" reform of the Sci-Tech Board [2][4]. Group 1: Company Overview - Wuhan He Yuan Bio Technology Co., Ltd. is the first company to initiate the issuance process after the re-launch of the fifth set of standards for the Sci-Tech Board [6]. - He Yuan Bio has developed a globally pioneering "rice-derived hematopoietic" technology, which has received support from the national "Major New Drug Creation" program [6]. - The company's innovative drug, recombinant human albumin injection (from rice), was approved for market release by the National Medical Products Administration in July, aiming to reduce China's reliance on imported human serum albumin [6]. Group 2: Market Context - The issuance of He Yuan Bio is a reflection of the policy direction to enhance the adaptability and inclusiveness of the Sci-Tech Board for high-quality technology enterprises [6]. - Since the announcement of the "1+6" reform policy in June, the Sci-Tech Board has received 15 new IPO applications, including four from unprofitable companies [9]. - The Shanghai Stock Exchange has completed the technical system testing for the new registration of the Sci-Tech Growth Layer, with 5 million investors already authorized to trade in this layer [10]. Group 3: Issuance Details - He Yuan Bio is the first company to adopt differentiated lock-up and allocation arrangements for offline issuance, with a minimum lock-up ratio of 40% for offline investors [6]. - The company has set three tiers of differentiated lock-up levels for investor bids, with the highest lock-up tier having a distribution ratio at least nine times that of the lowest tier [6][7]. - The recent revision of the issuance and underwriting rules by the Shanghai Stock Exchange allows unprofitable companies to adopt agreed lock-up methods, encouraging professional institutions to play a larger role in new stock pricing [7].

Group 1 - The article discusses the upcoming IPOs and their details, including the issuance price and market capitalization [1] - It highlights the strategic partnership between Lepu Medical and Hanhai Information Technology, focusing on market promotion and operations in the medical aesthetics sector [1] - The article mentions the collaboration between Tianci Materials and Ruipu Lanjun, indicating a potential growth opportunity [1] Group 2 - The article provides information on convertible bonds, including their current prices, redemption prices, and last trading dates [3][6] - It lists various convertible bonds with their respective market values and conversion ratios, indicating the financial health and market positioning of the companies involved [3][6] - The article emphasizes the importance of monitoring convertible bond performance as part of investment strategies [6]

证券日报网讯 9月22日晚间，中复神鹰发布公告称，本次股票上市类型为首发限售股份；股票认购方式 为网下，上市股数为298，399，282股。本次股票上市流通总数为298，399，282股。限售期为自公司股 票上市之日起42个月。本次股票上市流通日期为2025年10月9日（因2025年10月6日为非交易日，故顺延 至下一交易日）。 （编辑 楚丽君） ...

证券代码：688295 证券简称：中复神鹰 公告编号：2025-038 中复神鹰碳纤维股份有限公司 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 9 月 22 日 （二） 股东大会召开的地点：江苏省连云港市经济技术开发区大浦工业区公司 会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 106 | | --- | --- | | 普通股股东人数 | 106 | | 2、出席会议的股东所持有的表决权数量（股） | 804,478,243 | | 普通股股东所持有表决权数量（股） | 804,478,243 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 89.3864 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 89. ...

北京市嘉源律师事务所 关于中复神鹰碳纤维股份有限公司 2025年第二次临时股东大会的法律意见书 嘉源(2025)-04-700 北京市嘉源律师事务所 关于中复神鹰碳纤维股份有限公司 2025年第二次临时股东大会的 法律意见书 嘉源律师事务所 JIA YUAN LAW OFFICES 西城区复兴门内大街 158 号远洋大厦 4 楼 中国·北京 浪律师事务所 A YUAN LAW OFFICES 北京 BEIJING·上海 SHANGHAI·深圳 SHENZHEN·香港 HONG KONG·广州 GUANGZHOU·西安 XI'AN 致:中复神鹰碳纤维股份有限公司 北京市嘉源律师事务所(以下简称"本所")接受中复神鹰碳纤维股份有限公 司(以下简称"公司")的委托,根据《中华人民共和国公司法》(以下简称"《公 司法》")《上市公司股东会规则》(以下简称"《股东会规则》")等现行有效 的法律、行政法规、部门规章、规范性文件(以下简称"法律法规")以及《中复 神鹰碳纤维股份有限公司章程》(以下简称"《公司章程》")的有关规定,指派 本所律师对公司 2025 年第二次临时股东大会(以下简称"本次股东大会")进行 见证,并 ...

Investment Rating - The report maintains a "Buy" rating for the company [5] Core Views - The company achieved significant improvement in profitability in Q2 2025, marking its first profit in a year, with a revenue of 5.2 billion yuan, a year-on-year increase of 83% [2][3] - The carbon fiber market prices have stabilized at the bottom, contributing to the company's cost reduction efforts and improved profitability [2] - The company has seen a substantial increase in sales volume, particularly in the wind power sector, which grew over 200% year-on-year [3] Summary by Sections Financial Performance - In H1 2025, the company reported revenues of 9.2 billion yuan, a 26% increase year-on-year, while net profit was 0.12 billion yuan, down 52% year-on-year [1] - In Q2 2025, the company achieved a gross margin of 24.5%, up 4.2 percentage points year-on-year, and 21.1 percentage points quarter-on-quarter, reaching a new high since Q2 2024 [2] Cost Management - The company successfully reduced production costs by 4.55% year-on-year and management expenses by 44.93% in H1 2025 through various cost-saving initiatives [2] Sales Growth - The sales volume of 3K silk and other small filament products increased by 77% year-on-year, while high-strength and high-modulus series products saw a 53% increase [3] - The company has made significant breakthroughs in aerospace and other sectors, with core products like T800 grade carbon fiber showing steady growth [3] Investment Forecast - The profit forecast for the company has been adjusted upwards for 2025 and 2026, with expected net profits of 1.25 billion yuan and 1.57 billion yuan respectively, and a new forecast for 2027 at 2.15 billion yuan [3]

证券代码：688295 证券简称：中复神鹰 公告编号：2025-037 中复神鹰碳纤维股份有限公司 首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 298,399,282股。 本次股票上市流通总数为298,399,282股。限售期为自公司股票上市之日起 42 个月。 本次股票上市流通日期为2025 年 10 月 9 日。（因 2025 年 10 月 6 日为非 交易日，故顺延至下一交易日） 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2022 年 2 月 22 日出具的《关于同意中复神 鹰碳纤维股份有限公司首次公开发行股票注册的批复》（证监许可[2022]337 号）， 中复神鹰碳纤维股份有限公司（以下简称"公司"或"中复神鹰"）获准向社会 公众公开发行人民币普通股（A 股）100,000,000 股，并于 2022 年 4 月 6 日在上 海证券交易所科创板上市。公司首次公开发行股票完成后， ...

国泰海通证券股份有限公司 关于中复神鹰碳纤维股份有限公司 首次公开发行部分限售股上市流通的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 中复神鹰碳纤维股份有限公司（以下简称"中复神鹰"或"公司"）首次公开发 行股票并在科创板上市及持续督导的保荐机构，根据《证券发行上市保荐业务管 理办法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公 司自律监管指引第 1 号——规范运作》等法律法规的相关规定，对中复神鹰首次 公开发行部分限售股上市流通事项进行了核查，核查情况及核查意见如下: 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2022 年 2 月 22 日出具的《关于同意中复 神鹰碳纤维股份有限公司首次公开发行股票注册的批复》（证监许可[2022]337 号），中复神鹰获准向社会公众公开发行人民币普通股（A 股）100,000,000 股， 并于 2022 年 4 月 6 日在上海证券交易所科创板上市。公司首次公开发行股票完 成后，总股本为 900,000,000 股，其中有限售条件流通股 831,155,943 股，无限 售条件流通股 68,844, ...

Core Viewpoint - The petrochemical industry is currently experiencing a mixed performance, with the China Petroleum and Chemical Industry Index declining by approximately 1.4%. The industry is expected to benefit from policies aimed at structural adjustment and the elimination of outdated production capacity, particularly in the context of high capital expenditure cycles and new capacity releases [1][2]. Group 1: Industry Performance - The A-share market showed a slight opening increase followed by a mixed performance among the three major indices, with the China Petroleum and Chemical Industry Index declining [1]. - The petrochemical ETF (159731) followed the index's downward trend, highlighting the value of low-position investments [1]. Group 2: Upcoming Events - The "2025 China Petroleum and Chemical Industry High-Quality Development Conference" is scheduled for September 25-27, 2025, focusing on sustainable development and identifying growth opportunities in the petrochemical sector [1]. Group 3: Industry Analysis - Huatai Securities indicates that the chemical industry is in a high capital expenditure cycle, with many sub-industries facing profit troughs due to significant new capacity releases. The "anti-involution" policy is expected to assist in supply-side adjustments [1]. - Long-term benefits are anticipated for leading companies that leverage advantages in technology, scale, and management amid supply optimization and economic recovery [1]. Group 4: Sector Composition - The China Petroleum and Chemical Industry Index is composed of three major sectors: refining and trading (27.12%), chemical products (23.87%), and agricultural chemicals (19.75%), which are expected to benefit from policies aimed at structural adjustment and the elimination of outdated capacity [2].

Core Viewpoint - The carbon paper industry in China is experiencing rapid growth, driven by technological advancements and domestic substitution, with some products reaching international standards, although high-end equipment and batch consistency still rely on imports [1][2]. Group 1: Industry Overview - Carbon paper is a high-performance material made from short-cut carbon fibers, categorized into dry and wet processes, and is essential for fuel cells and electrolyzers [1][2]. - The industry is characterized by a complete ecosystem with upstream raw material supply, midstream manufacturing, and downstream applications, primarily driven by hydrogen fuel cell vehicles [5][7]. Group 2: Market Dynamics - The total production capacity of carbon fiber in China is projected to reach 144,000 tons per year by 2024, with an output of approximately 59,000 tons, supporting the carbon paper industry [7]. - The demand for gas diffusion layers in fuel cells is expected to exceed 20 million square meters by 2030, increasing the carbon paper market size from 312 million yuan in 2025 to 1.998 billion yuan in 2030 [1][8][11]. Group 3: Competitive Landscape - The competitive landscape is shifting from foreign monopoly to domestic leadership, with key players like State Power Investment Hydrogen Energy and Shanghai Carbon Industry leveraging proprietary technology and scale [11][12]. - The industry is witnessing a multi-tiered structure, with first-tier companies dominating through comprehensive technology and capacity, while second-tier firms focus on niche markets [11][12]. Group 4: Development Trends - The carbon paper industry is moving towards high performance, low cost, and an integrated ecosystem under the "dual carbon" goals, with expansion into new fields like hydrogen production and semiconductors [1][14]. - Technological advancements are driving the industry towards high precision and customization, with domestic companies overcoming key technical challenges and achieving import substitution [14][15]. - The market is expected to grow at an annual rate exceeding 40% due to policy support and increasing demand from the hydrogen and energy storage sectors [15][16].